Efficacy of and Factors Contributing to Dose Adjustment in Treatment with Certolizumab for Crohnʼs Disease: 1681
暂无分享,去创建一个
Dawn B. Beaulieu | D. Schwartz | S. Horst | M. Green | Caroline Duley | Julianne H. Wagnon | Anas Abou-Ishmail
暂无分享,去创建一个
Dawn B. Beaulieu | D. Schwartz | S. Horst | M. Green | Caroline Duley | Julianne H. Wagnon | Anas Abou-Ishmail